185 related articles for article (PubMed ID: 8671407)
1. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications.
Kol S; Lewit N; Itskovitz-Eldor J
Hum Reprod; 1996 Jun; 11(6):1143-4. PubMed ID: 8671407
[No Abstract] [Full Text] [Related]
2. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
Casper RF
Hum Reprod; 1996 Jun; 11(6):1144-6. PubMed ID: 8671408
[No Abstract] [Full Text] [Related]
3. Ovarian hyperstimulation: effects of GnRH analogues. Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase.
Ben-Arie A; Weissman A; Shoham Z
Hum Reprod; 1996 Jun; 11(6):1146-8. PubMed ID: 8671409
[No Abstract] [Full Text] [Related]
4. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study.
Lewit N; Kol S; Manor D; Itskovitz-Eldor J
Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474
[TBL] [Abstract][Full Text] [Related]
5. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
Weissman A; Barash A; Shapiro H; Casper RF
Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527
[TBL] [Abstract][Full Text] [Related]
6. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
Giles J; Requena A; García-Velasco JA; Pacheco A; Pellicer J; Pellicer A
Fertil Steril; 2009 Apr; 91(4 Suppl):1366-9. PubMed ID: 18692821
[TBL] [Abstract][Full Text] [Related]
7. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
[TBL] [Abstract][Full Text] [Related]
8. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
[TBL] [Abstract][Full Text] [Related]
9. Ovarian hyper-response to administration of an GnRH-agonist without gonadotropins.
Park HT; Bae HS; Kim T; Kim SH
J Korean Med Sci; 2011 Oct; 26(10):1394-6. PubMed ID: 22022197
[TBL] [Abstract][Full Text] [Related]
10. Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.
Brett S; Yong PY; Thong KJ
J Assist Reprod Genet; 2001 Jun; 18(6):353-6. PubMed ID: 11495415
[No Abstract] [Full Text] [Related]
11. [GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome].
Guivarc'h-Levêque A; Jaffré F; Homer L; Moy L; Priou G; Colleu D; Denis I; Arvis P
Gynecol Obstet Fertil; 2013 Sep; 41(9):511-4. PubMed ID: 23972925
[TBL] [Abstract][Full Text] [Related]
12. Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome.
Kasum M; Orešković S; Franulić D; Čehić E; Lila A; Vujić G; Grgić F
Acta Clin Croat; 2017 Mar; 56(1):133-142. PubMed ID: 29120551
[TBL] [Abstract][Full Text] [Related]
13. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
[TBL] [Abstract][Full Text] [Related]
14. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
[TBL] [Abstract][Full Text] [Related]
15. The prevention of ovarian hyperstimulation syndrome.
Corbett S; Shmorgun D; Claman P; ;
J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
[TBL] [Abstract][Full Text] [Related]
16. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
Fatemi HM; Garcia-Velasco J
Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740
[TBL] [Abstract][Full Text] [Related]
17. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
18. Preventing ovarian hyperstimulation with gonadotropin-releasing hormone agonist trigger: is anything perfect?
Filicori M
Fertil Steril; 2014 Apr; 101(4):936-7. PubMed ID: 24613536
[No Abstract] [Full Text] [Related]
19. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at 'freeze-all strategy'.
Ling LP; Phoon JW; Lau MS; Chan JK; Viardot-Foucault V; Tan TY; Nadarajah S; Tan HH
Reprod Biomed Online; 2014 Sep; 29(3):392-4. PubMed ID: 25042608
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
